Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRN | P28799 | 5/20 | 0.64 |
| ▸ | SORT1 | Q99523 | 5/20 | 0.64 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.53 |
| ▸ | MARS1 | P56192 | 1/20 | 0.53 |
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 1/20 | 0.46 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30812509 | 0.93 | GRN (0.55) | GRNSORT1P2RY14MARS1BRD4 | |
| SCHEMBL29006219 | 0.87 | GRN (0.50) | GRNSORT1P2RY14MMEPOLB | |
| SCHEMBL7192267 | 0.86 | P2RY14 (0.56) | GRNSORT1P2RY14MMEPTGER1 | |
| SCHEMBL17727584 | 0.86 | GRN (0.49) | GRNSORT1P2RY14MMEMEN1 | |
| SCHEMBL28339416 | 0.85 | GRN (0.59) | GRNSORT1P2RY14BRD4MME | |
| SCHEMBL20488433 | 0.85 | SMN1; SMN2 (0.53) | GRNSORT1P2RY14MARS1BRD4 | |
| SCHEMBL20488429 | 0.85 | BRD4 (0.72) | GRNSORT1P2RY14BRD4MME | |
| SCHEMBL7934400 | 0.84 | P2RY14 (0.55) | GRNSORT1P2RY14MMEPTGER1 | |
| SCHEMBL19737758 | 0.84 | SMN1; SMN2 (0.55) | GRNSORT1P2RY14MARS1BRD4 | |
| SCHEMBL15056101 | 0.83 | P2RY14 (0.53) | GRNSORT1P2RY14MARS1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3589618-B1 | PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE IP NO 2 LTD (GB) | 2022-12-28 | — | — | EP | disclosed |
| US-10966961-B2 | Pyrazole derivatives as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2021-04-06 | — | — | US | disclosed |
| EP-3215136-B1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NAT RECH SCIENT (FR) | 2021-03-24 | — | — | EP | disclosed |
| EP-3215136-B1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NAT RECH SCIENT (FR) | 2021-03-24 | — | — | EP | disclosed |
| WO-2018158212-A1 | PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2018-09-07 | — | — | WO | disclosed |
| US-20170360752-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-12-21 | — | — | US | disclosed |
| US-20170360752-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-12-21 | — | — | US | disclosed |
| US-20170360752-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-12-21 | — | — | US | disclosed |
| EP-3215136-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | Centre National de la Recherche Scientifique (CNRS) (FR) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016071470-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2016-05-12 | — | — | WO | disclosed |
| WO-2016071470-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2016-05-12 | — | — | WO | disclosed |
| EP-3017812-A1 | N1-Benzyl substituted pyrazoles as antiviral agents directed against respiratory synctical virus (RSV) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2016-05-11 | — | — | EP | disclosed |
| EP-3017812-A1 | N1-Benzyl substituted pyrazoles as antiviral agents directed against respiratory synctical virus (RSV) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2016-05-11 | — | — | EP | disclosed |
| US-20140128571-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-05-08 | — | — | US | disclosed |
| US-20130165630-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2013-06-27 | — | — | US | disclosed |
| US-20120302780-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-11-29 | — | — | US | disclosed |
| US-20110237776-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10966961-B2 | Pyrazole derivatives as bromodomain inhibitors | BRD3, BRD4, BRPF3 | GRN 2317/4885SORT1 4871/4885P2RY14 2287/4885 |
| US-20120302780-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | CBS, ARSA, SOD1 | GRN 780/4885SORT1 2654/4885P2RY14 2935/4885 |
| US-20140128571-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | SOD1, CBS, ABCB7 | GRN 734/4885SORT1 3066/4885P2RY14 3826/4885 |
| US-20170360752-A1 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | MAVS, ZC3HAV1, SARS1 | GRN 3885/4885SORT1 4037/4885P2RY14 2513/4885 |
| US-20110237776-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | SOD1, CBS, ABCB7 | GRN 734/4885SORT1 3066/4885P2RY14 3826/4885 |
| US-20130165630-A1 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS | SOD1, CBS, ABCB7 | GRN 734/4885SORT1 3066/4885P2RY14 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.